Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes

被引:7
|
作者
Nilsen, Tom [1 ,2 ]
Haugen, Siri Helen [1 ]
Larsson, Anders [2 ]
机构
[1] Gentian Technol AS, N-1596 Moss, Norway
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
antigen purification; calprotectin; chromatography; granulocyte; MRP8; MRP14;
D O I
10.1002/hsr2.35
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Calprotectin is a promising biomarker for granulocyte activation. It is mainly measured in faeces as a marker for inflammatory bowel disease. A limitation is that there is no widely accepted calibrator. Aim To establish a method for purification of calprotectin from human granulocytes that is easily reproducible, reliable, and could contribute to a better agreement between different calprotectin methods. Methods and results Calprotectin was purified from granulocyte extracts using ion-exchange chromatography. The granulocytes were separated from blood bags. The purity was analysed by analysing pixel density of a picture of the sodium dodecyl sulfate polyacrylamide gel electrophoresis and by size exclusion chromatography. The calprotectin concentration of the pure antigen solution was determined using Biuret method. The purity was >95% for 3 preparations, and their concentrations were 1079, 1080, and 1813 mg/L. Conclusion It is possible to reproducibly prepare highly purified calprotectin antigen from human granulocytes. The preparations can be used for preparing calibrators, controls for immunological calprotectin assays, and immunisation for raising antibodies against human calprotectin in hens.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] The role of S100A8, S100A9 and Calprotectin in skin inflammation
    Irigoyen, M. P.
    Bakiri, L.
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 : 6 - 7
  • [2] The role of S100A8, S100A9 and Calprotectin in skin inflammation
    Irigoyen, M. Palomo
    Bakiri, L.
    Wagner, E. F.
    [J]. FEBS OPEN BIO, 2022, 12 : 39 - 39
  • [3] Significance of S100A8, S100A9 and calprotectin levels in bladder cancer
    Yasar, O.
    Akcay, T.
    Obek, C.
    Turegun, F. A.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2017, 77 (06): : 437 - 441
  • [4] From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
    Inciarte-Mundo, Jose
    Frade-Sosa, Beatriz
    Sanmarti, Raimon
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [6] Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
    Shabani, Fatemeh
    Farasat, Alireza
    Mahdavi, Majid
    Gheibi, Nematollah
    [J]. INFLAMMATION RESEARCH, 2018, 67 (10) : 801 - 812
  • [7] Formation of Calprotectin Inhibits Amyloid Aggregation of S100A8 and S100A9 Proteins
    Baronaite, Ieva
    Sulskis, Darius
    Kopustas, Aurimas
    Tutkus, Marijonas
    Smirnovas, Vytautas
    [J]. ACS CHEMICAL NEUROSCIENCE, 2024, 15 (09): : 1915 - 1925
  • [8] Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
    Fatemeh Shabani
    Alireza Farasat
    Majid Mahdavi
    Nematollah Gheibi
    [J]. Inflammation Research, 2018, 67 : 801 - 812
  • [9] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
  • [10] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651